JACoW logo

Journals of Accelerator Conferences Website (JACoW)

JACoW is a publisher in Geneva, Switzerland that publishes the proceedings of accelerator conferences held around the world by an international collaboration of editors.


BiBTeX citation export for MOPOGE09: Commissioning Status of the iBNCT Accelerator

@inproceedings{sato:linac2022-mopoge09,
  author       = {M. Sato and Z. Fang and M.K. Fukuda and Y. Fukui and K. Futatsukawa and K. Ikegami and H. Kobayashi and C. Kubota and H. Kumada and T. Kurihara and Y. Matsumoto and T. Miura and T. Miyajima and N. Nagura and F. Naito and K. Nanmo and T. Obina and H. Oguri and T. Ohba and T. Shibata and T. Sugimura and A. Takagi and Su. Tanaka and T. Toyoshima},
% author       = {M. Sato and Z. Fang and M.K. Fukuda and Y. Fukui and K. Futatsukawa and K. Ikegami and others},
% author       = {M. Sato and others},
  title        = {{Commissioning Status of the  iBNCT Accelerator}},
  booktitle    = {Proc. LINAC'22},
% booktitle    = {Proc. 31st International Linear Accelerator Conference (LINAC'22)},
  pages        = {164--166},
  eid          = {MOPOGE09},
  language     = {english},
  keywords     = {target, neutron, operation, rfq, radiation},
  venue        = {Liverpool, UK},
  series       = {International Linear Accelerator Conference},
  number       = {31},
  publisher    = {JACoW Publishing, Geneva, Switzerland},
  month        = {09},
  year         = {2022},
  issn         = {2226-0366},
  isbn         = {978-3-95450-215-8},
  doi          = {10.18429/JACoW-LINAC2022-MOPOGE09},
  url          = {https://jacow.org/linac2022/papers/mopoge09.pdf},
  abstract     = {{An accelerator-based boron neutron capture therapy (BNCT) has been studied intensively in recent years as one of the new cancer therapies after many clinical research with nuclear reactors. In the iBNCT project, the accelerator configuration consists of an RFQ and a DTL which have proven achievements in J-PARC. Meanwhile, a high duty factor is required to have a sufficient thermal neutron flux needed by BNCT treatments. After a failure of the klystron power supply occurred in Feb. 2019, beam operation was resumed in May 2020. To date, an average current of about 2 mA with the beam repetition rate of 75 Hz has been achieved with stable operation. Irradiation tests with cells and mice are ongoing together with characteristic measurements of the neutron beam. In parallel with that, we have been gradually improving the accelerator cooling-water system for further stability. In this contribution, the present status and prospects of the iBNCT accelerator are reported.}},
}